Showing results (161-170 of 299) with videos related to
Sort By:
Pageof 30
Journal of the Intensive Care Society|October 6, 2017
Management of cardiac arrest survivors in UK intensive care units: a survey of practiceA H Ford, T Clark, E C Reynolds, et al.Bipolar Disorders|June 21, 2012
Will disruptive mood dysregulation disorder reduce false diagnosis of bipolar disorder in children?David M Margulies, Sheldon Weintraub, Joann Basile, et al.BMC Plant Biology|November 11, 2011
Loss-of-function mutations affecting a specific Glycine max R2R3 MYB transcription factor result in brown hilum and brown seed coatsJason D Gillman, Ashley Tetlow, Jeong-Deong Lee, et al.Journal of Cardiovascular Pharmacology|August 24, 2005
Negative inotropic effect of low-dose ethanol in mouse ventricular myocytes is mediated by activation of endothelial nitric oxide synthaseShengjun Zhang, Gary J Grover, Henry Stokes, et al.FEBS Open Bio|May 14, 2013
Bacterial biosensors for screening isoform-selective ligands for human thyroid receptors α-1 and β-1Izabela Gierach, Jingjing Li, Wan-Yi Wu, et al.British Journal of Anaesthesia|May 17, 2015
Evaluation of an intervention to reduce tidal volumes in ventilated ICU patientsC P Bourdeaux, K Birnie, A Trickey, et al.Journal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.The American Journal of Physiology|September 1, 1996
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideG J Grover, A J D'Alonzo, S Dzwonczyk, et al.Eneuro|May 13, 2020
Role of Synaptic Inhibition in the Coupling of the Respiratory Rhythms that Underlie Eupnea and Sigh BehaviorsDaniel S Borrus, Cameron J Grover, Gregory D Conradi Smith, et al.Journal of Cardiovascular Pharmacology|January 1, 1997
Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerationsG J Grover, P G Sleph, S Dzwonczyk, et al.Pageof 30